Wells Fargo & Company Ice Cure Medical Ltd. Call Options Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ICCM
# of Institutions
16Shares Held
195KCall Options Held
0Put Options Held
0-
Ubs Group Ag59.9KShares$65,8830.0% of portfolio
-
Xtx Topco LTD London, X026.3KShares$28,9420.0% of portfolio
-
Geode Capital Management, LLC Boston, MA25.6KShares$28,1160.0% of portfolio
-
Two Sigma Investments, LP New York, NY18.5KShares$20,3770.0% of portfolio
-
Virtu Financial LLC New York, NY14.6KShares$16,0340.0% of portfolio
About IceCure Medical Ltd.
- Ticker ICCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,835,600
- Market Cap $40.5M
- Description
- IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.